UNOPS hosts the Stop Tuberculosis Partnership Secretariat (STBP) as of 1 January 2015, in Geneva, Switzerland. The vision of the Stop TB Partnership is to realize the goal of elimination of Tuberculosis (TB) as a public health problem and, ultimately, to acquire a world free of TB by ensuring that every TB patient has access to effective diagnosis, treatment and cure; stopping transmission of TB; reducing the inequitable social and economic toll of TB; and developing and implementing new preventive, diagnostic and therapeutic tools and strategies. The Stop Partnership is uniquely positioned to support the development and further implementation by partners of the current and future Global Plan, acting as a coordinator and catalyst for the range of partners engaged in the fight against TB.
Founded in 2001, STBP's mission is to serve every person who is vulnerable to TB and ensure that high-quality treatment is available to all who need it. Stop TB partners include international and technical organizations, government programmes, research and funding agencies, foundations, NGOs, civil society and community groups and the private sector.
As a key initiative of the Stop TB Partnership, the objective of the Global Drug Facility (GDF), an ISO:9001:2015 certified entity, is to ensure access to quality-assured TB drugs, diagnostics, and other health products by employing innovative business approaches, efficient knowledge management for factual leadership in market management, strategic procurement, and high-quality procurement and supply services to client countries. GDF’s strategic vision of success is that all people requiring TB diagnostics and medicines can access them from markets optimized to meet public health needs.
The GDF procures all groups of medicines, key diagnostic tools and other health products that are currently recommended by WHO for diagnosis, prevention, and treatment of drug susceptible and resistant forms of TB. When procuring through GDF, countries are ensured to receive quality-assured TB products in compliance with WHO Prequalification Program or Stringent National Medicines Regulatory Authorities or the Global Fund – ERP program.
In addition, GDF applies an outstanding Drug Monitoring Program (DMP) coordinated with and performed by contracted Quality control agents which consists of the review of the manufacturer issued certificate of analysis for procured product batches, consignment pre-shipment inspection and sampling, and quality testing of product batches supplied to countries.
The Product Quality Officer will be part of the Strategic Procurement and Business Intelligence (SPBI) unit that aims to ensure timely access to quality-assured TB products appropriately adapted, affordable and sustainably priced. She/He will work under the supervision of the Lead Product Quality Officer and in close collaboration with other GDF teams and partners, to ensure that TB medicines, diagnostics and other health products procured and supplied by GDF to countries are quality assured and of adequate standard.
All activities performed by the Product Quality Officer will be implemented in accordance with the ISO9001:2015 GDF quality manual.
Work for this position calls for excellent technical and writing skills.